Valeant Pharmaceuticals International News

Valeant Pharmaceuticals International, Inc. announced today that Valeant has agreed to acquire certain assets from Swiss Herbal Remedies Limited, a nutraceutical company that manufactures and markets a broad range of scientifically formulated vitamins, minerals and supplements, for less than one times sales.

In trading on Wednesday, shares of Valeant Pharmaceuticals International Inc entered into oversold territory, hitting an RSI reading of 29.1, after changing hands as low as $47.29 per share.

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money.

NEW YORK &#8212 Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and Nasdaq Stock Market: NYSE Tyson Foods Inc., up 59 cents at $18.63 Thanks to charging more for its products, the chicken, beef and pork producer's second-quarter profit and revenue rose.

The trailing-twelve-month operating margin at Valeant Pharmaceuticals International Inc is 24.98%. VRX's revenue for the same period is $2.75 billion.

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.

Pro forma organic growth for the combined company, adjusting for the impact of foreign exchange and acquisitions, was approximately 11% "We are pleased to see a solid start to what we expect will be another strong year for Valeant," said , chairman and chief executive officer.

The companys products are used for the therapy areas including pain management, weight management, allergy, sexual health, dermatology, cardiology and respiratory health.

Valeant Pharmaceuticals International, Inc. has a deal to acquire AcneFree, an over-the-counter skin treatment for $64 million plus performance payments.